BlackRock’s Anebulo Pharmaceuticals ANEB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $24.8K | Buy |
17,213
+11,450
| +199% | +$16.5K | ﹤0.01% | 5037 |
|
|
2025
Q1 | $7.49K | Buy |
5,763
+1,834
| +47% | +$2.38K | ﹤0.01% | 5157 |
|
|
2024
Q4 | $6.6K | Buy |
3,929
+24
| +0.6% | +$40 | ﹤0.01% | 5148 |
|
|
2024
Q3 | $7.54K | Buy |
3,905
+144
| +4% | +$278 | ﹤0.01% | 4956 |
|
|
2024
Q2 | $10.3K | Sell |
3,761
-288
| -7% | -$786 | ﹤0.01% | 5018 |
|
|
2024
Q1 | $11.6K | Sell |
4,049
-96
| -2% | -$276 | ﹤0.01% | 5011 |
|
|
2023
Q4 | $10K | Sell |
4,145
-48
| -1% | -$116 | ﹤0.01% | 5071 |
|
|
2023
Q3 | $12.8K | Sell |
4,193
-3,060
| -42% | -$9.35K | ﹤0.01% | 5116 |
|
|
2023
Q2 | $17K | Sell |
7,253
-280
| -4% | -$658 | ﹤0.01% | 5130 |
|
|
2023
Q1 | $21.8K | Buy |
7,533
+240
| +3% | +$696 | ﹤0.01% | 5157 |
|
|
2022
Q4 | $17.7K | Buy |
7,293
+160
| +2% | +$388 | ﹤0.01% | 5306 |
|
|
2022
Q3 | $20K | Sell |
7,133
-200
| -3% | -$561 | ﹤0.01% | 5422 |
|
|
2022
Q2 | $38K | Sell |
7,333
-120
| -2% | -$622 | ﹤0.01% | 5375 |
|
|
2022
Q1 | $53K | Sell |
7,453
-360
| -5% | -$2.56K | ﹤0.01% | 5323 |
|
|
2021
Q4 | $49K | Buy |
7,813
+200
| +3% | +$1.25K | ﹤0.01% | 5329 |
|
|
2021
Q3 | $50K | Sell |
7,613
-160
| -2% | -$1.05K | ﹤0.01% | 5215 |
|
|
2021
Q2 | $53K | Buy |
+7,773
| New | +$53K | ﹤0.01% | 5104 |
|